Healthcare Market Research Reports

Titlepublishedprice

Myanmar Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......2013 to MMK387.5bn (USD390mn) in 2014; +19.3% in local currency terms and +11.3% in US dollar terms. Forecast unchanged from previous quarter. ? Healthcare Expenditure: MMK1,047.3bn (USD1.1bn) in 2013 to MMK1,217.9bn (USD1.2bn) in 2014; +16.3% in loc......"
17-Sep-2014$1295

Slovenia Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......s room for the new government to increase funding for health services, and we expect healthcare spending to decline this year and next, before returning to modest growth in 2016. Headline Expenditure Projections ? Pharmaceuticals: EUR720mn (USD960mn)......"
17-Sep-2014$1295

United States Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......atented, generic and over-the-counter medicines. State-level pharmaceutical markets in the country are larger than many country-level pharmaceutical markets. Headline Expenditure Projections ? Pharmaceuticals: USD347.2bn in 2013 to USD352.8bn in 2014......"
17-Sep-2014$1295

Global Spectrum Analyzer Market 2014-2018

By Infiniti Research Limited
"......rameters. It is used mainly in the spectrum analysis of various waveforms, the measurement of field strength, measurements on transmitted signals, and interference emission. Spectrum analyzer is largely used within the Electronics industry for analyz......"
17-Sep-2014$2500

Austria Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......ch to market healthcare technologies, while one of its domestic pharmaceutical firms has announced success in developing a cure for Alzheimer's. We believe that this would spur inward investment in the Austrian healthcare sector. A separate report sh......"
17-Sep-2014$1295

Bangladesh Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......that ongoing tax reform efforts by the government will rake in more revenues to support development spending, and keep the country's budget deficit manageable at around 3.0% of GDP over the coming years, the lack of government revenues remains a majo......"
17-Sep-2014$1295

Central America Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......ities for multimodal pharmaceutical companies. Headline Expenditure Projections ? Pharmaceuticals: USD3.5bn in 2013 to USD3.7bn in 2014; +4.1%. Our forecast has been revised slightly down since Q314 due to less promising industry data. ? Healthcare: ......"
17-Sep-2014$1295

Iran Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......ernational relations have reduced the regulatory risk associated with operating in the market for multinational drugmakers, the recent proclamation of the Islamic State (IS) in neighbouring Iraq and Syria increases the threat of political instability......"
17-Sep-2014$1295

Ireland Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......r mergers and redomiciling in Ireland for tax saving purposes, is expected to continue over the near term. More broadly, due to potential acquisitive interest in different Irish pharmaceutical equities, as well as the Irish industry reputation in pha......"
17-Sep-2014$1295

Kazakhstan Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......ore funds to constructing new health clinics across the country. Although Kazakhstan's growing pharmaceutical industry will be driven by demand for generic medicines over the medium term, we believe that there are also significant opportunities for p......"
17-Sep-2014$1295
Live Chat
Live Chat by Comm100